These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 18720240)

  • 1. Mechanoradical-induced degradation in a pharmaceutical blend during high-shear processing.
    Polizzi MA; Singhal D; Colvin J
    Pharm Dev Technol; 2008; 13(6):457-62. PubMed ID: 18720240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An investigation into the effects of excipient particle size, blending techniques and processing parameters on the homogeneity and content uniformity of a blend containing low-dose model drug.
    Alyami H; Dahmash E; Bowen J; Mohammed AR
    PLoS One; 2017; 12(6):e0178772. PubMed ID: 28609454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of compacted hydrophobic and hydrophilic colloidal silicon dioxide on tableting properties of pharmaceutical excipients.
    Jonat S; Hasenzahl S; Gray A; Schmidt PC
    Drug Dev Ind Pharm; 2005 Aug; 31(7):687-96. PubMed ID: 16207616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of carrier excipient and processing on stability of indorenate hydrochloride/excipient mixtures.
    Villalobos-Hernández JR; Villafuerte-Robles L
    Pharm Dev Technol; 2001 Nov; 6(4):551-61. PubMed ID: 11775956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of water in the physical stability of solid dosage formulations.
    Airaksinen S; Karjalainen M; Shevchenko A; Westermarck S; Leppänen E; Rantanen J; Yliruusi J
    J Pharm Sci; 2005 Oct; 94(10):2147-65. PubMed ID: 16136577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of colloidal silica on rheological properties of common pharmaceutical excipients.
    Majerová D; Kulaviak L; Růžička M; Štěpánek F; Zámostný P
    Eur J Pharm Biopharm; 2016 Sep; 106():2-8. PubMed ID: 27163240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of excipients, drugs, and osmotic agent in the inner core on the time-controlled disintegration of compression-coated ethylcellulose tablets.
    Lin SY; Lin KH; Li MJ
    J Pharm Sci; 2002 Sep; 91(9):2040-6. PubMed ID: 12210050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clarifying the mechanism of aggregation of particles in high-shear granulation based on their surface properties by using micro-spectroscopy.
    Kano T; Yoshihashi Y; Yonemochi E; Terada K
    Int J Pharm; 2014 Jan; 461(1-2):495-504. PubMed ID: 24368102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A formulation strategy for solving the overgranulation problem in high shear wet granulation.
    Osei-Yeboah F; Zhang M; Feng Y; Sun CC
    J Pharm Sci; 2014 Aug; 103(8):2434-40. PubMed ID: 24985120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of drug-excipient interaction in the formulation of celecoxib tablets.
    Bozdağ-Pehlivan S; Subaşi B; Vural I; Unlü N; Capan Y
    Acta Pol Pharm; 2011; 68(3):423-33. PubMed ID: 21648198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In situ monitoring of the crystalline state of active pharmaceutical ingredients during high-shear wet granulation using a low-frequency Raman probe.
    Nomura K; Titapiwatanakun V; Hisada H; Koide T; Fukami T
    Eur J Pharm Biopharm; 2020 Feb; 147():1-9. PubMed ID: 31841690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Powder flow in an automated uniaxial tester and an annular shear cell: a study of pharmaceutical excipients and analytical data comparison.
    Kuentz M; Schirg P
    Drug Dev Ind Pharm; 2013 Sep; 39(9):1476-83. PubMed ID: 23043592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Instrumented roll technology for the design space development of roller compaction process.
    Nesarikar VV; Vatsaraj N; Patel C; Early W; Pandey P; Sprockel O; Gao Z; Jerzewski R; Miller R; Levin M
    Int J Pharm; 2012 Apr; 426(1-2):116-131. PubMed ID: 22286023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surface engineered excipients: I. improved functional properties of fine grade microcrystalline cellulose.
    Chen L; Ding X; He Z; Huang Z; Kunnath KT; Zheng K; Davé RN
    Int J Pharm; 2018 Jan; 536(1):127-137. PubMed ID: 29191481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved blend and tablet properties of fine pharmaceutical powders via dry particle coating.
    Huang Z; Scicolone JV; Han X; Davé RN
    Int J Pharm; 2015 Jan; 478(2):447-55. PubMed ID: 25475016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The mechanical properties of compacts of microcrystalline cellulose and silicified microcrystalline cellulose.
    Edge S; Steele DF; Chen A; Tobyn MJ; Staniforth JN
    Int J Pharm; 2000 Apr; 200(1):67-72. PubMed ID: 10845687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utilizing quantitative certificate of analysis data to assess the amount of excipient lot-to-lot variability sampled during drug product development.
    Kushner J
    Pharm Dev Technol; 2013; 18(2):333-42. PubMed ID: 21877870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug release and swelling kinetics of directly compressed glipizide sustained-release matrices: establishment of level A IVIVC.
    Sankalia JM; Sankalia MG; Mashru RC
    J Control Release; 2008 Jul; 129(1):49-58. PubMed ID: 18456362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Challenges in Transitioning Cocrystals from Bench to Bedside: Dissociation in Prototype Drug Product Environment.
    Koranne S; Sahoo A; Krzyzaniak JF; Luthra S; Arora KK; Suryanarayanan R
    Mol Pharm; 2018 Aug; 15(8):3297-3307. PubMed ID: 29947519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of dibutyrylchitin as new excipient for sustained drug release.
    Casettari L; Cespi M; Castagnino E
    Drug Dev Ind Pharm; 2012 Aug; 38(8):979-84. PubMed ID: 22124336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.